Article Review: What Autologous Wound Care Solutions Exist for Full-Thickness Skin Defects?

By Nikolai Sopko, MD, PhD Chief Scientific Officer & Chief Operating Officer, PolarityBio

In recent posts, we’ve examined two questions that continue to shape modern wound care: whether living cells matter in advanced therapies, and whether the source of those cells—autologous or allogeneic meaningfully changes the biology of healing.

If you accept that cells matter, and that autologous biology offers unique advantages, the next logical question is a practical one: what autologous wound care solutions are actually available today?

That question is the focus of a peer-reviewed publication I co-authored in Surgical Technology International, Addressing Full-Thickness Skin Defects: A Review of Clinically Available Autologous Skin Replacements. Rather than defining regeneration, this article examines the real-world limitations of traditional grafting and surveys the spectrum of autologous approaches developed to address full-thickness wounds when standard options fall short.

Skin Repair Versus Skin Regeneration

As detailed in the publication, skin is not a passive barrier but a complex organ system with layered architecture, appendages, neural and vascular networks, and immune functionality. When full-thickness skin is lost, the body defaults to repair through contraction and scar formation—restoring continuity, but not normal structure or function.

This distinction between repair and regeneration frames the evaluation of every skin-replacement strategy discussed in the review.

Traditional Grafting: Effective Coverage, Incomplete Restoration

Split-Thickness and Full-Thickness Skin Grafts

Autologous skin grafting remains the standard of care for many large wounds. However, split-thickness skin grafts fail to capture deeper dermal components, appendages, and regenerative niches. They also create permanent donor-site morbidity and produce recipient skin that lacks durability, elasticity, and normal function.

Full-thickness grafts better preserve architecture but are limited by donor-site closure requirements and are not suitable for many chronic or ischemic wounds.

Micrografting Techniques: Expanding Coverage, Not Biology

The review examines several micrografting strategies developed to maximize expansion while minimizing donor-site burden:

Meek Grafting

Originally developed in the 1950s and later refined, Meek grafting divides autologous split-thickness skin into small postage-stamp-sized islands, allowing predictable expansion ratios up to 9:1. The literature cited in the review shows strong graft “take” rates and improved resistance to infection, particularly in burn patients.

Key limitation: While effective for epithelialization, Meek grafting does not regenerate full skin architecture or appendages.

Pixel Grafting

Pixel grafting further miniaturizes graft size (≈0.3 mm²), increasing epithelial edge density and accelerating re-epithelialization in preclinical models. As discussed in the publication, pixel grafting improves speed of closure but still results in skin that heals primarily through repair mechanisms rather than true regeneration.

Minced and Micrograft Systems

Technologies such as minced skin and micrograft devices demonstrate impressive expansion ratios (up to 1:100) and promote cytokine release and angiogenesis. However, as noted in the review, these approaches rely heavily on the wound environment to supply the biological signals needed for durable healing—an issue particularly relevant in chronic wounds.

This directly echoes themes discussed in our post on Cellular vs Acelluar treatments: Cells or No Cells, where structural approaches alone may be insufficient when host biology is compromised.

Cultured Epithelial Autografts: Cells Without Structure

The publication provides a detailed analysis of cultured epithelial autografts (CEA)—one of the earliest cellular skin-replacement technologies.

CEA enables dramatic keratinocyte expansion and has proven lifesaving in large burn injuries. However, the review highlights persistent limitations:

·       Absence of dermal components and rete ridges

·       High susceptibility to shear and infection

·       Variable graft take, especially in chronic wounds

·       Long production timelines and high cost

These findings reinforce points made in the previously mentioned post, the presence of cells alone does not guarantee regeneration if architectural and biological context is missing.

Autologous Cell Suspensions and Microcolumn Grafting

Autologous skin cell suspensions deliver keratinocytes, melanocytes, and fibroblasts directly to wounds commonly used in combination with split-thickness skin grafting. Clinical trials demonstrate comparable wound closure outcomes to meshed grafts, but with decreased donor-site requirements.

Microcolumn grafting, inspired by fractional laser injury, represents a shift toward preserving full-thickness skin units. Preclinical and early clinical data suggest improved architectural restoration with reduced donor-site impact, signaling a move closer to regeneration rather than repair.

A Shift Toward Endogenous Regeneration

A central conclusion of the publication is that regenerating skin requires more than epithelial coverage. Full restoration depends on the function of endogenous regenerative populations found within the dermis and appendages—stem-cell niches that coordinate angiogenesis, innervation, immune signaling, and tissue organization. Because of their role in healing, these populations are an active area of research in preclinical studies.   

This concept directly aligns with themes explored in our recent article on Autologous vs Allogeneic, where therapies that retain native biology may integrate more naturally and mature more completely over time.

Looking Forward: Beyond Closure

As emphasized in the Surgical Technology International article, the future of wound care lies in therapies that aim not just for closure, but for functional skin restoration, including elasticity, sensation, appendages, and durability.

Taken together, the progression from acellular to cellular, allogeneic to autologous, and repair to regeneration reflects an evolving understanding of what true healing should look like.

Skin is not simply something to cover. It is something to regenerate.

Reference

Adapted from: Milner S, Swanson E, Granick M, Sopko N. Addressing Full-Thickness Skin Defects: A Review of Clinically Available Autologous Skin Replacements. Surg Technol Int. 2021 May 20;38:73-78. doi: 10.52198/21.STI.38.WH1403. PMID: 33755940.

Previous
Previous

What Does “Regenerative” Actually Mean in Wound Care?

Next
Next

Understanding FDA Pathways for Human Cell and Tissue Products: 361 HCT/P vs. 351 Biologic License Application